Nov 17 (Reuters) - Advance ZincTek ANO.AX:
FDA INSPECTION UPDATE
FDA IDENTIFIES GMP COMPLIANCE ISSUES REQUIRING REMEDIATION
CURRENTLY NO IMPACT ON SUPPLY TO OUR U.S. CUSTOMERS
FDA ALSO CONFIRMED THAT MATTERS RAISED IN ITS APRIL 2024 LETTER HAVE BEEN SATISFACTORILY CLOSED
Further company coverage: ANO.AX
((Reuters.Briefs@thomsonreuters.com;))